CompoundLink

An Exciting New Chapter in OTC Drug History: OTC Monograph Reform in the CARES Act fda.gov/news-events/fd…

“Agency Information Collection Activities; Proposed Collection; Comment Request; Obtaining Information To Understand Challenges and Opportunities Encountered by Compounding Outsourcing Facilities”...regulations.gov/document?D=FDA…

FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder fda.gov/drugs/drug-saf…

Exclusive: After pandemic, U.S. senators want review of drug supply chain | Article [AMP] | Reuters reuters.com/article/us-hea…

Remdesivir by Gilead Sciences: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of Treatment fda.gov/safety/medical…

FDA revokes emergency use authorization for chloroquine, hydroxychloroquine fxn.ws/3e5TKBM

Rare Disease Therapy Development and Access Remain Top FDA Priorities During COVID-19 fda.gov/news-events/fd…

“Policy Updates to FDA Guidances on Compounding Certain Drugs for Hospitalized COVID-19 Patients” fda.gov/drugs/coronavi…

Updated: Temporary Policy Regarding Non-Standard PPE Practices for Sterile Compounding by Pharmacy Compounders not Registered as Outsourcing Facilities During the COVID-19 Public Health Emergency fda.gov/regulatory-inf…

FDA Announces Latest Step Toward Finalizing Memorandum of Understanding with States Addressing Compounded Drug Distribution, While Preserving Access fda.gov/news-events/fd…

“Morphine Sulfate and Epinephrine added to FDA guidances on compounding certain drugs for hospitalized COVID-19 patients”... bit.ly/35TM3ev and bit.ly/2yM5vhe

COVID-19 drug shortages reveal potential issues with global supply chain youtu.be/k26Dfok8Uts via @YouTube

Famotidine Shortages Continue Amid Pandemic drugtopics.com/article/famoti…

CDC - Recommended Guidance for Extended Use and Limited Reuse of N95 Filtering Facepiece Respirators in Healthcare Settings - NIOSH Workplace Safety and Health Topic cdc.gov/niosh/topics/h… via @CDCgov

Outsourcing facilities that produce compounded drugs play a pivotal role in the coronavirus pandemic by ensuring that hospitals have access to critical medications. businesswire.com/news/home/2020…

APC & NASPA have released suggested state bd of pharmacy guidelines for overseeing 503A sterile compounders providing COVID shortage drugs to hospitals under FDA temporary guidance. @InHealthPolicy reports here: insidehealthpolicy.com/share/114615 @StatePharmacy @commpharmacy @pharmacists

Temporary Policy on Repackaging or Combining Propofol Drug Products During the COVID-19 Public Health Emergency fda.gov/regulatory-inf…

Coronavirus (COVID-19) Update: FDA Continues to Ensure Availability of Alcohol-Based Hand Sanitizer During the COVID-19 Pandemic, Addresses Safety Concerns fda.gov/news-events/pr…

Hydroxychloroquine or Chloroquine for COVID-19: Drug Safety Communication - FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems fda.gov/safety/medical…

Temporary Policy on Repackaging or Combining Propofol Drug Products During the COVID-19 Public Health Emergency fda.gov/regulatory-inf…